The neutrophil–lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003–2016

Table 2 The relationships between NLR and mortality in diabetes

Characteristic	Crude model		Model 1		Model 2
Characteristic	HR (95% CI)	p	HR (95% CI)	p	HR (95% CI)	p
All-cause mortality
NLR	1.18 (1.12,1.24)	< 0.0001	1.13 (1.08,1.19)	< 0.0001	1.14 (1.10,1.19)	< 0.0001
NLR category
Lower NLR (n = 2784)	Ref		Ref		Ref
Higher NLR (n = 467)	2.89 (2.39,3.49)	< 0.0001	2.13 (1.75,2.60)	< 0.0001	2.03 (1.64,2.51)	< 0.0001
Cardiovascular mortality
NLR	1.21 (1.12,1.30)	< 0.0001	1.27 (1.17,1.38)	< 0.0001	1.27 (1.17,1.38)	< 0.0001
NLR category
Lower NLR (n = 2317)	Ref		Ref		Ref
Higher NLR (n = 299)	3.53 (2.52,4.94)	< 0.0001	2.71 (1.84,3.99)	< 0.0001	2.76 (1.84,4.14)	< 0.0001

Crude Model, unadjusted; Model 1, adjusted for age, sex, race, BMI, smoking status and drinking status; Model 2, adjusted for age, sex, race, BMI, smoking status, drinking status, hypertension, HDL, LDL, TG, TC, HbA1c, education level, family income-to-poverty ratio, and eGFR

ISSN: 1475-2840